JPRN-UMIN000040945已完成1 期
The Efficacy of Safe and Sound Protocol on auditory hypersensitivity and communication deficits in children with autism spectrum disorder - The Efficacy of Safe and Sound Protocol on auditory hypersensitivity and communication deficits in children with autism spectrum disorder
ational Center for Child Health and Development0 个研究点目标入组 15 人开始时间: 2020年7月14日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 3years-old 至 12years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with a serious physical disease or motor disfunction 2) Patients with a hereditary disease 3) Patients with a history of epilepsty
研究者
相似试验
撤回
不适用
A Master Protocol Evaluating the Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC);-Subprotocol A: A Phase 1b Study Evaluating the Safety and Efficacy of AMG 160 in Combination With Enzalutamide in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC) -Subprotocol B: A Phase 1b Study Evaluating the Safety and Efficacy of AMG 160 in Combination With Abiraterone in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)prostaat kankerMetastatic Castration-resistant10036958prostate cancerNL-OMON54909Amgen6
进行中（未招募）
1 期
A Master Protocol Evaluating the Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate CancerMetastatic Castration-resistant Prostate CancerMedDRA version: 21.1Level: LLTClassification code 10076506Term: Castration-resistant prostate cancerSystem Organ Class: 100000004864EUCTR2020-001305-23-DEAmgen129
进行中（未招募）
1 期
A Master Protocol Evaluating the Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate CancerMetastatic Castration-resistant Prostate CancerMedDRA version: 21.1Level: LLTClassification code 10076506Term: Castration-resistant prostate cancerSystem Organ Class: 100000004864EUCTR2020-001305-23-DKAmgen136
进行中（未招募）
1 期
A Master Protocol Evaluating the Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate CancerMetastatic Castration-resistant Prostate CancerMedDRA version: 21.1Level: LLTClassification code 10076506Term: Castration-resistant prostate cancerSystem Organ Class: 100000004864EUCTR2020-001305-23-ITAMGEN INC.105
进行中（未招募）
1 期
A Master Protocol Evaluating the Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate CancerMetastatic Castration-resistant Prostate CancerMedDRA version: 21.1Level: LLTClassification code 10076506Term: Castration-resistant prostate cancerSystem Organ Class: 100000004864EUCTR2020-001305-23-NLAmgen105